Testing effectiveness (Phase 2)Ended earlyNCT06910384
What this trial is testing
STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS)
Who this might be right for
Amyotrophic Lateral Sclerosis
New England Cell Therapeutics, Inc. 1
Showing 20 of 0 results